PTBP3 modulates P53 expression and promotes colorectal cancer cell proliferation by maintaining UBE4A mRNA stability

Canbin Xie1, Fei Long1, Liang Li1

  • 1Department of Gastrointestinal Surgery, The Third XiangYa Hospital of Central South University, Changsha, Hunan, 410013, China.

Cell Death & Disease
|February 9, 2022
PubMed

Insights

The RNA binding protein PTBP3 promotes colorectal cancer (CRC) growth by stabilizing UBE4A, which degrades P53. PTBP3 may serve as a prognostic biomarker and therapeutic target for CRC patients.

Area of Science:

  • Molecular Oncology
  • RNA Biology

Background:

  • The RNA binding protein PTBP3 is implicated in various cancers.
  • Its specific role in colorectal cancer (CRC) is not well understood.

Purpose of the Study:

  • To investigate the role and molecular mechanisms of PTBP3 in colorectal cancer (CRC).

Main Methods:

  • PTBP3 expression analysis in CRC tissues.
  • PTBP3 knockdown in CRC cell lines (in vitro and in vivo).
  • Analysis of UBE4A and P53 expression and interaction with PTBP3 mRNA.

Main Results:

  • PTBP3 is upregulated in CRC and correlates with poor prognosis.
  • PTBP3 knockdown inhibits CRC cell proliferation.
  • PTBP3 stabilizes UBE4A mRNA, leading to P53 degradation.
  • UBE4A overexpression rescues PTBP3 knockdown effects.

Conclusions:

  • PTBP3 promotes CRC proliferation by stabilizing UBE4A and regulating P53.
  • PTBP3 is a potential prognostic biomarker and therapeutic target for CRC.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.4K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
7.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K